Guidant Plans CRT Trial Aimed At Slowing Heart Failure In Healthier Patients
This article was originally published in The Gray Sheet
Executive Summary
Expansion of the approved indication for cardiac resynchronization therapy (CRT) to include early-stage heart failure (HF) patients will be pursued by Guidant via its planned MADIT-CRT trial, the firm says